|
|
| | ent-Aprepitant Basic information |
| Product Name: | ent-Aprepitant | | Synonyms: | Aprepitant Related Compound B (10 mg) (3-[[(2S,3R)-2-[(S)-1-[3,5-Bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)morpholino]methyl]-1H-1,2,4-triazol-5(4H)-one);ent-Aprepitant;[2S-[2α(R*),3α]]-5-[[2-[1-[3,5-Bis(trifluoroMethyl)phenyl]ethoxy]-3-(4-fluorophenyl)-4-Morpholinyl]Me;5-[[(2S,3R)-2-[(1S)-1-[3,5-Bis(trifluoroMethyl)phenyl]ethoxy]-3-(4-fluorophenyl)-4-Morpholinyl]Methyl]-1,2-dihydro-3H-1,2,4-triazol-3-one;Aprepitant Related CoMpound B;Aprepitant EP Impurity D;Aprepitant B;Aprepitant R C B (USP) | | CAS: | 172822-29-6 | | MF: | C23H21F7N4O3 | | MW: | 534.43 | | EINECS: | | | Product Categories: | Chiral Reagents;Heterocycles;Intermediates & Fine Chemicals;Pharmaceuticals | | Mol File: | 172822-29-6.mol |  |
| | ent-Aprepitant Chemical Properties |
| density | 1.51±0.1 g/cm3(Predicted) | | pka | 8.06±0.20(Predicted) |
| | ent-Aprepitant Usage And Synthesis |
| Uses | ent-Aprepitant (Aprepitant EP Impurity D) is the (S,R,S)-enantiomer of Aprepitant (A729800), an unwanted enantiomer of Aprepitant in bulk drug and formulation samples of Aprepitant. |
| | ent-Aprepitant Preparation Products And Raw materials |
|